Acta Haematologica

Papers
(The H4-Index of Acta Haematologica is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Treating Leukemia in the Time of COVID-1943
Systematic Review of Microthrombi in COVID-19 Autopsies32
Red Blood Cell Distribution Is a Significant Predictor of Severe Illness in Coronavirus Disease 201926
Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic26
Accelerated Phase of Myeloproliferative Neoplasms25
Hematological Manifestations among Patients with Rheumatic Diseases21
A Prospective Pilot Study of Graft-versus-Host Disease Prophylaxis with Post-Transplantation Cyclophosphamide and Ruxolitinib in Patients with Myelofibrosis21
COVID-19 Coagulopathy: From Pathogenesis to Treatment18
The Association between Metabolic Syndrome and Multiple Myeloma17
Coronavirus Disease 2019 (COVID-19): A Haematologist’s Perspective16
Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel15
G-CSF and GM-CSF Are Different. Which One Is Better for COVID-19?14
Current Treatment of Refractory/Relapsed Chronic Lymphocytic Leukemia: A Focus on Novel Drugs13
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations13
0.030205011367798